SENTINEL NODE BIOPSY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Key Takeaways from Analyst

The global sentinel node biopsy market is expected to grow steadily, driven by rising breast cancer and melanoma cases. The Asia Pacific region is forecast to be the fastest-growing due to increasing healthcare spending and awareness, while North America will maintain its dominance due to advanced healthcare infrastructure and adoption of cutting-edge medical techniques.

The market is supported by the benefits of sentinel node biopsies, including accurate staging, minimally invasive procedures, and fewer side effects compared to traditional methods. Additionally, the increasing expertise of surgeons and the rise of one-day surgery centers are contributing to market expansion.

Opportunities lie in the growth of medical tourism, ongoing research, and new product innovations, including ultrasound guidance systems, radioisotope tracers, and robot-assisted devices. Collaborations with hospitals and surgical centers are also key strategies for market penetration.